Home / Without Label / CBIO Catalyst Biosciences, Inc. gains 46% Oct 12, 2017

Thursday, October 12, 2017

CBIO Catalyst Biosciences, Inc. gains 46% Oct 12, 2017

priceSeries Thursday, October 12, 2017 0 Comment

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-46-percent-a-Trade-Record-by-priceSeries-2017091220171012.html

Posted by : priceSeries Thursday, October 12, 2017

No Comments

Subscribe to: Post Comments (Atom)